July 2016

UC Office of the President July 25, 2016 University of California announces UCI team, led by UCI MIND co-director Dr. Joshua Grill, as a recipient of the UC Cures for Alzheimer’s award. Read more..."Joshua Grill, associate professor in the department of psychiatry and human behavior at UC Irvine, will lead a team to study the effects of high doses of vitamin nicotinamide in reducing tau phosphorylation in patients with Alzheimer’s disease..."

July 22, 2016 The latest findings from The 90+ Study were recently published in the Journal of the American Geriatrics Society (JAGS) by UCI MIND's Szofia Bullain MD, Maria Corrada ScD, Shawna Perry MS, and Claudia Kawas MD.  Dr. Bullain will be discussing the article and its findings on Doctor Radio, SiriusXM channel 110 from 2:00-2:30pm PT Monday, July 25.  Don't miss this exciting update! Don't have a subscription to SiriusXM?  Sign up for a free 30-day online pass  and listen online. The show will also be posted here ~48 hours after the show. Read the full paper here.  

Nell Redmond, AP July 20, 2016 USA Today "Nearly 45 years after his last Cup race, Lorenzen hoped he would still make his mark on the NASCAR community. Inspired by Dale Earnhardt Jr.'s decision to pledge his brain to the Concussion Legacy Foundation, Lorenzen became the second known driver to make the same decision."        

July 19, 2016 MariaShriver.com UCI MIND Co-Director Dr. Joshua Grill and A4 Study Project Leader Dr. Reisa Sperling work to understand the heavy burden Alzheimer's disease places on women-- and what women can do to help today.    

July 18, 2016 Alzforum The Senate Committee drafted a bill with a $400 million hike in AD research funding last month.  The House crafted their version of the bill last Friday.  See how their proposal stacks up.

UCI MIND & Alzheimer's Orange County are excited to announce the 27th Annual Southern California Alzheimer's Disease Research Conference!  Nationally-renowned experts will address the latest advances in Alzheimer’s and dementia research across unique populations, such as victims of head trauma and people living with Down syndrome.  Join over 400 community members, clinicians, researchers, students, service providers, and caregivers on September 30, 2016 at the Irvine Marriott Hotel. Continuing education credits and discounted student rates are available.  Register online today!

  July 13, 2016 HealthCanal Read about Professor David Cribbs' global partnership in developing anti-amyloid-beta & anti-tau vaccines with "promise for both preventive & therapeutic approaches in AD." more>

"Dear Dr. Grill, My Mom is interested in taking part in a “transparent” preclinical trial on Alzheimer’s disease. As part of the study, she would undergo Positron Emission Tomography, also called a PET scan. Because this is a transparent study, I understand she’ll receive the results of this PET scan. What kind of support should I seek for my Mom if the results show she has amyloid in her brain, a biomarker for Alzheimer’s? Are transparent studies becoming more common for Alzheimer’s disease?" Read Dr. Grill's response here>

"Dear Dr. Grill, My Mom is interested in taking part in a “transparent” preclinical trial on Alzheimer’s disease. As part of the study, she would undergo Positron Emission Tomography, also called a PET scan. Because this is a transparent study, I understand she’ll receive the results of this PET scan. What kind of support should I seek for my Mom if the results show she has amyloid in her brain, a biomarker for Alzheimer’s? Are transparent studies becoming more common for Alzheimer’s disease?" Read Dr. Grill's response here>

Washington Post "I believe that Pat died to demonstrate that the day in, day out way we treat people with cognitive decline has to get better. You’d like to think that Pat got the kind of generous, sensitive care that she gave to others. But the fact is, she didn’t always, for the simple reason that not enough of that care exists. We can do something about that."   more>